tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BMY Stock Latest News

Bristol Myers says EC grants approval to Breyanzi for treatment of MCL
The FlyBristol Myers says EC grants approval to Breyanzi for treatment of MCL
1d ago
BMY
Bayer data could ‘somewhat renew’ optimism for Bristol drug, says Morgan Stanley
PremiumThe Fly
Bayer data could ‘somewhat renew’ optimism for Bristol drug, says Morgan Stanley
1d ago
BMY
Video: Biogen up after Novo weight-loss drug fails to slow Alzheimer’s progress
PremiumThe Fly
Video: Biogen up after Novo weight-loss drug fails to slow Alzheimer’s progress
1d ago
MP
BMY
Texas AG sues Sanofi, Bristol Myers over alleged Plavix inefficacy
PremiumThe Fly
Texas AG sues Sanofi, Bristol Myers over alleged Plavix inefficacy
5d ago
BMY
SNY
Bristol-Myers Squibb: Balancing Phase III Setbacks with Future Opportunities in Stroke and Atrial Fibrillation
PremiumRatings
Bristol-Myers Squibb: Balancing Phase III Setbacks with Future Opportunities in Stroke and Atrial Fibrillation
5d ago
BMY
Bristol-Myers Squibb Adjusts Tender Offer Terms
PremiumCompany AnnouncementsBristol-Myers Squibb Adjusts Tender Offer Terms
7d ago
8K
BMY
Bristol Myers price target lowered to $45 from $48 at Citi
Premium
The Fly
Bristol Myers price target lowered to $45 from $48 at Citi
8d ago
BMY
Bristol-Myers Squibb Faces Setbacks with Milvexian Trials, Justifying Sell Rating
Premium
Ratings
Bristol-Myers Squibb Faces Setbacks with Milvexian Trials, Justifying Sell Rating
10d ago
BMY
Bristol Myers Squibb put volume heavy and directionally bearish
PremiumThe Fly
Bristol Myers Squibb put volume heavy and directionally bearish
11d ago
BMY
Bristol Myers falls 4% to $46.41 after stopping Phase 3 Librexia ACS trial
PremiumThe Fly
Bristol Myers falls 4% to $46.41 after stopping Phase 3 Librexia ACS trial
11d ago
BMY
Bristol Myers to stop Phase 3 Librexia ACS trial of milvexian
PremiumThe Fly
Bristol Myers to stop Phase 3 Librexia ACS trial of milvexian
11d ago
BMY
JNJ
Nike upgraded, Dollar Tree downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Nike upgraded, Dollar Tree downgraded: Wall Street’s top analyst calls
12d ago
AZO
BMY
Scotiabank starts 10 large cap drugmakers with ‘out-of-consensus’ positive view
PremiumThe FlyScotiabank starts 10 large cap drugmakers with ‘out-of-consensus’ positive view
12d ago
BMY
JNJ
Bristol Myers initiated with a Sector Perform at Scotiabank
Premium
The Fly
Bristol Myers initiated with a Sector Perform at Scotiabank
13d ago
BMY
Pharma firms spending billions on treatments based off old drugs, Bloomberg says
Premium
The Fly
Pharma firms spending billions on treatments based off old drugs, Bloomberg says
13d ago
BMY
MRK
FDA appoints Richard Pazdur as Director of CDER
PremiumThe Fly
FDA appoints Richard Pazdur as Director of CDER
14d ago
AZN
BMY
Bristol-Myers Squibb Completes €5 Billion Note Offering
PremiumCompany Announcements
Bristol-Myers Squibb Completes €5 Billion Note Offering
15d ago
8K
BMY
Cytokinetics price target raised to $90 from $80 at B. Riley
PremiumThe Fly
Cytokinetics price target raised to $90 from $80 at B. Riley
15d ago
BMY
CYTK
Bristol Myers price target lowered to $62 from $64 at Piper Sandler
PremiumThe Fly
Bristol Myers price target lowered to $62 from $64 at Piper Sandler
15d ago
BMY
Bristol Myers treatment of pancreatic cancer granted orphan status
PremiumThe FlyBristol Myers treatment of pancreatic cancer granted orphan status
15d ago
BMY
Private Markets: Anthropic projects $70B in revenue in 2028
Premium
The Fly
Private Markets: Anthropic projects $70B in revenue in 2028
18d ago
S
BMY
Bristol Myers reaches $239M settlement over Otezla, Zeposia, Reuters reports
Premium
The Fly
Bristol Myers reaches $239M settlement over Otezla, Zeposia, Reuters reports
19d ago
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >